Compounded semaglutide products are not reviewed, evaluated, or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality. Use of compounded semaglutide carries potential risks, serious contraindications, and may not be available in all states or through all providers. Compounded medications are prescribed and dispensed under the oversight of licensed healthcare professionals in compliance with applicable federal and state laws. KonnectMD and JoinKonnectMD.com are not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S, the owner of the registered trademarks Ozempic®, Wegovy®, or Rybelsus®. All trademarks remain the property of their respective owners.
Patients are strongly encouraged to consult with their licensed healthcare provider to determine whether compounded medications are appropriate for their individual medical needs and circumstances.
Home